OGTT demonstrated similar clinical utility as the two-hour OGTT in dysglycemia reclassification among postpartum individuals.

One-hour glucose was strongest predictor of dysglycemia on regression analyses, followed by 2-hour glucose. (HealthDay News) — Higher 1-hour blood glucose on an oral glucose tolerance test (OGTT ...

A 1-hour postpartum oral glucose tolerance test (OGTT) outperformed the standard 2-hour test for predicting future dysglycemia in women with and without a history of gestational diabetes ...

Opko Health and Entera Bio have formalized their partnership as the biotechs prepare to take the first orally administered dual agonist glucagonlike-peptide 1 (GLP-1)/glucagon peptide into the clinic.